Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort
2008-2017 年 ESME 队列中 20446 例转移性乳腺癌患者的总生存期和新疗法接受情况的演变
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2021.100114
Grinda, T; Antoine, A; Jacot, W; Blaye, C; Cottu, P-H; Diéras, V; Dalenc, F; Gonçalves, A; Debled, M; Patsouris, A; Mouret-Reynier, M-A; Mailliez, A; Clatot, F; Levy, C; Ferrero, J-M; Desmoulins, I; Uwer, L; Petit, T; Jouannaud, C; Lacroix-Triki, M; Deluche, E; Robain, M; Courtinard, C; Bachelot, T; Brain, E; Pérol, D; Delaloge, S